Daejeon St. Mary's Hospital
Clinical trials sponsored by Daejeon St. Mary's Hospital, explained in plain language.
-
Heart failure drug vericiguat faces new test in tricuspid regurgitation patients
Disease control Not yet recruitingThis study tests whether the drug vericiguat can improve right heart function and reduce tricuspid regurgitation in 100 adults with heart failure and reduced pumping ability. Participants take vericiguat daily for 9 months, with regular heart scans and walking tests to measure ef…
Phase: PHASE4 • Sponsor: Daejeon St. Mary's hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could one month of blood thinners be enough after heart artery treatment?
Disease control Not yet recruitingThis study compares 1 month versus the standard 6 months of dual antiplatelet therapy (two blood thinners) in people who had a balloon procedure for small coronary artery disease. About 1,484 adults with stable angina or silent ischemia will be randomly assigned to either short o…
Phase: PHASE4 • Sponsor: Daejeon St. Mary's hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC